 | |
Headquarters in Nihonbashi Mitsui Tower
| |
Native name | 中外製薬株式会社 |
|---|---|
Romanized name | Chūgai Seiyaku kabushiki gaisha |
| Company type | Public KK |
|
| |
| Industry | Pharmaceutical Industry, Business import, production and development of drugs for medical sales |
| Founded | March 8, 1943; 81 years ago (1943-03-08) |
| Headquarters | Nihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo On the registration Headquarter: Tokyo Kita (Tokyo) |
Key people | Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO |
| Revenue | 72.9 billion capital of 47 million yen. Standalone sales of 329.2 billion yen and 344.8 billion yen consolidated (December 2007) |
| Parent | Hoffmann-La Roche (61.62%) |
| Website | www |
Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014.[1] The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.
This is a timeline of important events of Chugai Pharmaceutical.[2]
| International |
|
|---|---|
| National |
|
 | This article about a Japanese corporation- or company-related topic is a stub. You can help Wikipedia by expanding it. |
